Treatment of Acute Otitis Externa in Children Less Than 1 Year Old
Topical ofloxacin otic solution is the recommended first-line treatment for acute otitis externa in children less than 1 year old, administered as five drops (0.25 mL) once daily for seven days. 1
First-Line Treatment
Medication Selection
- Ofloxacin 0.3% otic solution is FDA-approved for children as young as 6 months old 1
- Dosage: Five drops (0.25 mL, 0.75 mg ofloxacin) instilled into the affected ear once daily for seven days 1
- Ofloxacin is preferred over aminoglycoside-containing drops (e.g., neomycin) due to:
Administration Technique
- Warm the solution by holding the bottle in hand for 1-2 minutes to prevent dizziness 1
- Position child with affected ear upward 1
- Instill five drops into the ear canal 1
- Maintain position for 5 minutes to facilitate penetration 1
- Repeat for opposite ear if necessary 1
Alternative Treatment Options
If ofloxacin is unavailable or ineffective after 48-72 hours:
- Ciprofloxacin otic solution (with or without dexamethasone) is an effective alternative 2
- For severe cases with signs of systemic infection, consider adding systemic antibiotics 5, 2
Special Considerations for Infants
Proper Ear Canal Cleaning:
Assessment for Tympanic Membrane Perforation:
Monitoring and Follow-up
- Assess response within 48-72 hours of starting treatment 2
- Schedule follow-up in 7-10 days to confirm resolution 2
- If symptoms persist beyond 7 days despite appropriate therapy, consider:
Common Pathogens
- Pseudomonas aeruginosa (most common in otitis externa) 4, 6
- Staphylococcus aureus 4
- Consider MRSA in recurrent or recalcitrant cases 5
Potential Adverse Effects
- Generally well-tolerated with minimal side effects 3
- Most common adverse events:
Water Precautions
- Keep ear dry during treatment 2
- Use earplugs or cotton with petroleum jelly before bathing 2
- Avoid swimming until infection resolves 2
The once-daily regimen of ofloxacin offers significant advantages in treating infants, including excellent efficacy, safety profile, and improved adherence compared to more frequent dosing schedules 4, 6. This approach minimizes the risk of ototoxicity while providing effective coverage against the common pathogens causing otitis externa in this age group.